Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.49.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used